Lebenthal Asset Management’s Novartis NVS Stock Holding History

Lebenthal Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$4.68M	Buy	70,387 +3,813	+6%	+$254K	0.58%	46
2016 Q4	$4.34M	Buy	66,574 +3,012	+5%	+$195K	0.56%	50
2016 Q3	$4.5M	Buy	63,562 +5,808	+10%	+$423K	0.58%	47
2016 Q2	$4.27M	Buy	57,754 +2,593	+5%	+$179K	0.55%	51
2016 Q1	$3.58M	Buy	+55,161	New	+$3.75M	1.45%	35

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Lebenthal Asset Management's NVS Position: Q1 2017 in Review

Lebenthal Asset Management increased its Novartis (NVS) stake by 5.7% in Q1 2017, buying an estimated $254K and bringing the position to 70,387 shares worth $4.68M. The position accounts for 0.58% of the portfolio, ranked #46.

Lebenthal Asset Management first reported a position in NVS in Q1 2016 and has held it in 5 quarters since. 909 funds tracked by Wall St. Rank hold NVS as of Q1 2017.

Lebenthal Asset Management held 70,387 shares of Novartis worth $4.68M as of Q1 2017.
Lebenthal Asset Management bought 3,813 Novartis shares in Q1 2017, an estimated $254K.
Novartis made up 0.58% of Lebenthal Asset Management's portfolio in Q1 2017, its #46 holding.
Lebenthal Asset Management first reported a position in Novartis in Q1 2016 and has held it in 5 quarters since.
909 funds tracked by Wall St. Rank held Novartis as of Q1 2017.

Based on Lebenthal Asset Management's 13F filing for Q1 2017, filed 15 May 2017.